Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Allergy Clin Immunol ; 104(2 Pt 1): 388-94, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10452761

RESUMO

BACKGROUND: Recent observations show that atopic asthmatic subjects have increased sensitivity to respirable endotoxin (or LPS) compared with normal persons. In vitro studies demonstrate that LPS enhances eosinophil survival. These observations suggest that the effects of inhaled LPS in asthmatic subjects may include increases in the number of airway eosinophils. OBJECTIVE: We sought to determine whether low-level nasal LPS challenge causes an increase in eosinophil numbers in the nasal airways of atopic or normal subjects. METHODS: Sixteen volunteers (10 atopic asthmatic subjects and 6 normal subjects) underwent 2 nasal challenge sessions. In one session, one nostril was challenged with saline and the other with 0. 1 microg of LPS. During the second session, 0.3 microg and 1.0 microg of LPS was delivered to each nostril, respectively. Nasal lavage fluid was obtained from each nostril before challenge, as well as 4 and 24 hours after challenge, and examined for the percent of total cells that were eosinophils and neutrophils, as well as cytokine levels. RESULTS: LPS (1.0 microg) increased the percent of eosinophils in nasal lavage fluid 4 hours after challenge in atopic subjects only. There was also a correlation between constitutive nasal GM-CSF and eosinophil response to LPS in atopic subjects. CONCLUSION: LPS challenge increases eosinophils in the airways of atopic subjects.


Assuntos
Eosinófilos/citologia , Lipopolissacarídeos/farmacologia , Mucosa Nasal/citologia , Ribonucleases , Adolescente , Adulto , Asma/patologia , Proteínas Sanguíneas/metabolismo , Movimento Celular/efeitos dos fármacos , Proteínas Granulares de Eosinófilos , Feminino , Fator Estimulador de Colônias de Granulócitos e Macrófagos/metabolismo , Granulócitos/citologia , Humanos , Hipersensibilidade Imediata/patologia , Mediadores da Inflamação/metabolismo , Interleucina-8/metabolismo , Masculino , Pessoa de Meia-Idade , Mucosa Nasal/química , Testes de Provocação Nasal , Projetos Piloto
2.
Neurotoxicol Teratol ; 14(4): 285-90, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1522833

RESUMO

It has been shown that with increased carboxyhemoglobin (COHb) and associated decrease in blood oxygen-carrying capacity, a compensatory increase in brain-blood flow (BBF) develops. The BBF response in humans has been shown to be quite variable. Two experiments were conducted in which humans were exposed to sufficient carbon monoxide (CO) to produce COHb levels up to 18.4%. BBF was measured by the method of impedance plethysmography. The first was a pilot study in which BBF in 14 men was studied after transient exposure to various concentrations of CO in air. BBF increased as a function of COHb but not to the same extent (or at all) in some subjects. In a confirmatory experiment with 12 men, BBF was measured once per h during a 4-h experiment. All 12 subjects received CO. The variation of the BBF response among subjects was large and statistically significant whereas the variation over time was not significant. Thus it appears that the magnitude of the BBF response is unique for a given subject and differs across subjects. These results may help predict CO-induced behavioral decrements in future studies if subjects whose BBF response to COHb is small or absent are also more susceptible to impairment by acute CO exposure.


Assuntos
Monóxido de Carbono/administração & dosagem , Carboxihemoglobina/fisiologia , Circulação Cerebrovascular/efeitos dos fármacos , Carboxihemoglobina/análise , Humanos , Masculino , Projetos Piloto , Pletismografia de Impedância
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...